Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:RD-101
|
| gptkbp:focus |
infectious diseases
|
| gptkbp:founded |
gptkb:2020
|
| gptkbp:founder |
W. Michael Mc Cully
|
| gptkbp:headquarters |
gptkb:Miami,_Florida
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ridgeback Biotherapeutics
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:notable_products |
gptkb:Remdesivir
|
| gptkbp:partnership |
gptkb:Gilead_Sciences
|
| gptkbp:type |
private company
|
| gptkbp:website |
ridgebackbio.com
|